Journal
IMMUNITY
Volume 37, Issue 3, Pages 574-587Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2012.06.016
Keywords
-
Categories
Funding
- NIH [R21 CA143748, R01 DK066917, U19 AI066313]
- US DOD [W81XWH-09-1-0156]
- UNESCO L'Oreal
- European Commission
- Science Foundation Ireland
- Health Research Board, Ireland
Ask authors/readers for more resources
Invariant natural killer T (iNKT) cells are evolutionarily conserved innate T cells that influence inflammatory responses. We have shown that iNKT cells, previously thought to be rare in humans, were highly enriched in human and murine adipose tissue, and that as adipose tissue expanded in obesity, iNKT cells were depleted, correlating with proinflammatory macrophage infiltration. iNKT cell numbers were restored in mice and humans after weight loss. Mice lacking iNKT cells had enhanced weight gain, larger adipocytes, fatty livers, and insulin resistance on a high-fat diet. Adoptive transfer of iNKT cells into obese mice or in vivo activation of iNKT cells via their lipid ligand, alpha-galactocylceramide, decreased body fat, triglyceride levels, leptin, and fatty liver and improved insulin sensitivity through anti-inflammatory cytokine production by adipose-derived iNKT cells. This finding highlights the potential of iNKT cell-targeted therapies, previously proven to be safe in humans, in the management of obesity and its consequences.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available